Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg

NCT07266766 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: Empagliflozin / Metformin HCl XR Tablets
DRUG: Synjardy® XR (empagliflozin and metformin hydrochloride extended-release Tablets)

Sponsor

Humanis Saglık Anonim Sirketi